Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat
ClinicoEconomics and Outcomes Research, 2017 Richard Sheer,1 Kyle D Null,2 Keith A Szymanski,2 Lavanya Sudharshan,1 Jennifer Banovic,2 Margaret K Pasquale1 1Comprehensive Health Insights, Inc., Louisville, KY, 2Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA Purpose: Clinical guidelines ...
Sheer R +5 more
doaj
The use of febuxostat for gout in Hospital Tengku Ampuan Afzan (HTAA) Kuantan [PDF]
, 2017 Hilmi Abdullah
openalex
Comparison between Allopurinol and Febuxostat in management of gout patients - a prospective study
, 2012 KK Singal +3 more
openalex +2 more sources
Febuxostat Prevents the Cytotoxicity of Propofol in Brain Endothelial Cells [PDF]
, 2021 Jianli Hao +3 more
openalex +1 more source
Allopurinol and Febuxostat Equally Attenuate Methotrexate-Induced Testicular Injury In Rats Via Activation Of EGF/ ERK1/2/HO‐1 Signaling Pathway. [PDF]
, 2021 Remon Roshdy Rofaeil +3 more
openalex +1 more source
XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis [PDF]
, 2017 Mahendra Damarla +9 more
openalex +1 more source
Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System [PDF]
, 2020 Yasir A. Al-Amodi +4 more
openalex +1 more source
Febuxostat in the management of hyperuricemia and chronic gout: a review
Therapeutics and Clinical Risk Management, 2008 Miao Hu, Brian TomlinsonDivision of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, ChinaAbstract: Febuxostat is a novel, potent, non ...
Miao Hu, Brian Tomlinson
doaj